Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Calcitriol Effects on Dopamine in Opioid Use Disorder
NCT06261905Phase 1Completed
- Sponsor
- Yale University
- Start
- Mar 2024
- Primary completion
- Feb 2025
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in opioid use disorder (OUD) comparing Calcitriol Condition with Placebo Condition (2 arms). Primary endpoint: Non-displaceable Tracer Binding Potential at 120 minutes. Started Mar 2024; status: completed.
02
Drugs
calcitriol
03
Conditions
opioid use disorder (OUD)
Beyond the preview
Go deeper on NCT06261905.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06261905.